AAPL311.12-1.54 (-0.49%) ▼|ABBV254.89+0.13 (+0.05%) ▲|ABT95.88+0.25 (+0.26%) ▲|ACN142.12+5.16 (+3.76%) ▲|ADBE221.74+3.67 (+1.68%) ▲|AMAT551.27-41.52 (-7.00%) ▼|AMD513.74-38.32 (-6.94%) ▼|AMGN368.55+2.11 (+0.57%) ▲|AMT165.33+3.22 (+1.99%) ▲|AMZN246.16+2.00 (+0.82%) ▲|AVGO370.16-3.74 (-1.00%) ▼|AXP349.67-6.36 (-1.79%) ▼|BA231.63-2.91 (-1.24%) ▼|BAC59.85-0.05 (-0.08%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.20-2.01 (-0.20%) ▼|BMY57.98+1.28 (+2.25%) ▲|BNY152.92+2.96 (+1.97%) ▲|BRK-B504.06-2.53 (-0.50%) ▼|C140.75-3.11 (-2.16%) ▼|CAT940.08-29.85 (-3.08%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.84-3.66 (-1.77%) ▼|COP108.43+4.85 (+4.68%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.50+3.85 (+2.32%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX173.94+5.84 (+3.47%) ▲|DE603.59-31.65 (-4.98%) ▼|DHR194.17+0.55 (+0.28%) ▲|DIS97.46+0.05 (+0.06%) ▲|DUK128.25+2.28 (+1.81%) ▲|EMR137.89-3.67 (-2.59%) ▼|FDX312.85+2.92 (+0.94%) ▲|GD374.62-2.27 (-0.60%) ▼|GE366.94-11.74 (-3.10%) ▼|GEV1,077.50-74.54 (-6.47%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.04-1.82 (-2.33%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,041.52-13.77 (-1.30%) ▼|HD345.22-5.43 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.14+6.62 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.25+7.92 (+3.05%) ▲|JPM339.18+1.46 (+0.43%) ▲|KO84.00+1.04 (+1.25%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.65+35.59 (+2.97%) ▲|LMT535.14-2.86 (-0.53%) ▼|LOW220.86-2.92 (-1.30%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.79-1.32 (-0.25%) ▼|MCD282.14+2.64 (+0.94%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.84+0.78 (+0.94%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.00-1.15 (-0.72%) ▼|MO72.95+1.07 (+1.49%) ▲|MRK128.88+2.10 (+1.66%) ▲|MS222.08-0.03 (-0.01%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.45+1.01 (+1.16%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.20-0.15 (-0.33%) ▼|NOW110.69+2.76 (+2.55%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.64-2.12 (-1.47%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.74+3.43 (+2.29%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.75+2.99 (+1.62%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.84-0.54 (-0.27%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.91+1.29 (+1.28%) ▲|SO97.28+1.29 (+1.34%) ▲|SPG227.09+2.09 (+0.93%) ▲|T21.06+0.48 (+2.33%) ▲|TMO516.40-1.20 (-0.23%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.18+10.19 (+2.44%) ▲|UNP283.02+0.43 (+0.15%) ▲|UPS111.95+1.93 (+1.75%) ▲|USB62.91+0.08 (+0.13%) ▲|V352.06-5.19 (-1.45%) ▼|VZ42.55+0.48 (+1.13%) ▲|WFC87.19-0.27 (-0.30%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.65+5.21 (+3.81%) ▲|AAPL311.12-1.54 (-0.49%) ▼|ABBV254.89+0.13 (+0.05%) ▲|ABT95.88+0.25 (+0.26%) ▲|ACN142.12+5.16 (+3.76%) ▲|ADBE221.74+3.67 (+1.68%) ▲|AMAT551.27-41.52 (-7.00%) ▼|AMD513.74-38.32 (-6.94%) ▼|AMGN368.55+2.11 (+0.57%) ▲|AMT165.33+3.22 (+1.99%) ▲|AMZN246.16+2.00 (+0.82%) ▲|AVGO370.16-3.74 (-1.00%) ▼|AXP349.67-6.36 (-1.79%) ▼|BA231.63-2.91 (-1.24%) ▼|BAC59.85-0.05 (-0.08%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.20-2.01 (-0.20%) ▼|BMY57.98+1.28 (+2.25%) ▲|BNY152.92+2.96 (+1.97%) ▲|BRK-B504.06-2.53 (-0.50%) ▼|C140.75-3.11 (-2.16%) ▼|CAT940.08-29.85 (-3.08%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.84-3.66 (-1.77%) ▼|COP108.43+4.85 (+4.68%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.50+3.85 (+2.32%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX173.94+5.84 (+3.47%) ▲|DE603.59-31.65 (-4.98%) ▼|DHR194.17+0.55 (+0.28%) ▲|DIS97.46+0.05 (+0.06%) ▲|DUK128.25+2.28 (+1.81%) ▲|EMR137.89-3.67 (-2.59%) ▼|FDX312.85+2.92 (+0.94%) ▲|GD374.62-2.27 (-0.60%) ▼|GE366.94-11.74 (-3.10%) ▼|GEV1,077.50-74.54 (-6.47%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.04-1.82 (-2.33%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,041.52-13.77 (-1.30%) ▼|HD345.22-5.43 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.14+6.62 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.25+7.92 (+3.05%) ▲|JPM339.18+1.46 (+0.43%) ▲|KO84.00+1.04 (+1.25%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.65+35.59 (+2.97%) ▲|LMT535.14-2.86 (-0.53%) ▼|LOW220.86-2.92 (-1.30%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.79-1.32 (-0.25%) ▼|MCD282.14+2.64 (+0.94%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.84+0.78 (+0.94%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.00-1.15 (-0.72%) ▼|MO72.95+1.07 (+1.49%) ▲|MRK128.88+2.10 (+1.66%) ▲|MS222.08-0.03 (-0.01%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.45+1.01 (+1.16%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.20-0.15 (-0.33%) ▼|NOW110.69+2.76 (+2.55%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.64-2.12 (-1.47%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.74+3.43 (+2.29%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.75+2.99 (+1.62%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.84-0.54 (-0.27%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.91+1.29 (+1.28%) ▲|SO97.28+1.29 (+1.34%) ▲|SPG227.09+2.09 (+0.93%) ▲|T21.06+0.48 (+2.33%) ▲|TMO516.40-1.20 (-0.23%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.18+10.19 (+2.44%) ▲|UNP283.02+0.43 (+0.15%) ▲|UPS111.95+1.93 (+1.75%) ▲|USB62.91+0.08 (+0.13%) ▲|V352.06-5.19 (-1.45%) ▼|VZ42.55+0.48 (+1.13%) ▲|WFC87.19-0.27 (-0.30%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.65+5.21 (+3.81%) ▲|
21.8 C
New York
Tuesday, July 7, 2026

Tag: risk

newssourceFORcompanyinformationcontent1releasesmarket

IUAV UNIVERSITY OF VENICE LAUNCHES THE WATER LAB: THREE NEW MASTER’S PROGRAMMES FOR FUTURE ENGINEERS AND PLANNERS

In Italy, the Blue Economy is worth €178 billion but this sector is under threat from the climate emergency. Iuav University of Venice has...

Deepcoin Integrates TradingView Webhook for Automated Perpetual Trading Execution

GRAND CAYMAN, Cayman Islands, June 23, 2025 /PRNewswire/ -- Deepcoin, a leading cryptocurrency derivatives trading platform, has officially integrated its perpetual trading system with...

Unleash Your Inner Investor: Jessie Harper’s Take on Tesla’s Potential

Hey there, fabulous money mavens! 💁‍♀️ Let's dive into the world of Tesla and the optimistic forecasts made by Cathie Wood's Ark Invest. If...

Fletcher Zone Maiden Mineral Resource of 2.3Moz

Stage 1 Fletcher Resource almost doubles the current Beta Hunt Resource PERTH, Western Australia, June 23, 2025 /CNW/ - Westgold Resources Limited (ASX: WGX) (TSX: WGX)...

Steelmaker SSAB, the manufacturer of Hardox® wear plate, cracks down on counterfeit goods

MELBOURNE, Australia, June 23, 2025 /PRNewswire/ -- SSAB has taken decisive action against two Indian companies selling counterfeit steel. The unauthorised products, labelled with...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /CNW/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are...

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular benefits...

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Bagsværd, Denmark, 22 June 2025 – Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout period or Mim8 loading dose, was well-tolerated with no safety concerns in adults and adolescents living with haemophilia A, with or without inhibitors1. Additionally, a FRONTIER5 Patient-Reported Outcomes (PROs) assessment found the Mim8 pen-injector easy to use, with an overall strong user preference for the pen-injector compared to the previous emicizumab injection system2,3. The results were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Cyberway Product Innovation Platform: Empowering Enterprise Innovation Processes and Building Exceptional Product Strength

GUANGZHOU , June 22, 2025 /PRNewswire/ -- In the fiercely competitive FMCG market, only efficient innovation can create a true competitive edge. As consumer preferences...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRisk

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers